Regulation of amyloid production by focused ultrasound
聚焦超声调节淀粉样蛋白的产生
基本信息
- 批准号:10511752
- 负责人:
- 金额:$ 51.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAmericanAmyloidAmyloid ProteinsAmyloid beta-ProteinAmyloid beta-Protein PrecursorAnimalsBlood - brain barrier anatomyBrainCholesterolCollaborationsDisease ProgressionEnvironmentEnzymesFocused UltrasoundGanglioside GM1ImageIndividualInflammasomeInflammationInflammatoryLabelLipidsMechanicsMembraneMicrobubblesMolecularMonitorMovementMusNeurodegenerative DisordersPhysicsProductionProteinsProtocols documentationRegulationResearchResearch InstituteResolutionSignal TransductionSliceSonicationTLR4 geneTNF geneTechniquesTestingWorkamyloid formationbeta secretasebiophysical techniquesbrain tissuecostexperiencegamma secretasegenetic risk factormechanical forcemouse modelnanoscaleneuroinflammationpreventprotein aggregationprotein functionprotein transportresponsesecretaseshear stresstooltraffickingultrasound
项目摘要
PROJECT SUMMARY
Beta amyloid (Aβ) is a protein that aggregates to form plaques associated with Alzheimer disease (AD). Its
formation from amyloid precursor protein (APP) by hydrolytic enzymes beta and gamma secretases is regulated
by brain cholesterol and depends on clustering of the proteins. In this application we propose to use focus
ultrasound (FUS) to disrupt cholesterol’s clustering of APP and inflammatory regulators toll like receptor 4 (TLR4)
and tumor necrosis factor alpha (TNF𝛼) which are also contributors to AD. We hypothesize, in that FUS can
reverse the effects cholesterol in an AD brain.
To test our hypothesis, we propose two specific aims. First, we will analyze clustering of amyloid proteins APP
and gamma secretase with and without FUS using dSTORM super resolution imaging in a mouse model of AD.
In a second aim we will characterize the de-clustering of inflammatory proteins TLR4 and TNF𝛼 in response to
FUS also in an AD mouse model.
The premise of this work is that cholesterol regulates nanoscopic trafficking of proteins in the membrane and
FUS disrupts the trafficking. Completion of the studies establish a direct molecular mechanism for FUS
independent of opening the blood brain barrier and FUS protocols with the potential to prevent or stop AD
progression.
项目总结
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cholesterol's Function and Origin in the Alzheimer's Disease Brain.
- DOI:10.3233/jad-230538
- 发表时间:2023-06
- 期刊:
- 影响因子:0
- 作者:S. Hansen
- 通讯作者:S. Hansen
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott B Hansen其他文献
Scott B Hansen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott B Hansen', 18)}}的其他基金
The role of lipid raft disruption in the activation of TREK-1 channels by anesthetics
脂筏破坏在麻醉剂激活 TREK-1 通道中的作用
- 批准号:
10595454 - 财政年份:2019
- 资助金额:
$ 51.52万 - 项目类别:
The role of lipid raft disruption in the activation of TREK-1 channels by anesthetics
脂筏破坏在麻醉剂激活 TREK-1 通道中的作用
- 批准号:
10394912 - 财政年份:2019
- 资助金额:
$ 51.52万 - 项目类别:
The role of lipid raft disruption in the activation of TREK-1 channels by anesthetics
脂筏破坏在麻醉剂激活 TREK-1 通道中的作用
- 批准号:
10158518 - 财政年份:2019
- 资助金额:
$ 51.52万 - 项目类别:














{{item.name}}会员




